(Q38230205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Restoring TRAIL mediated signaling in ovarian cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Ilhan Yaylim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Nazlı Ezgi Ozkan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Farrukh Zaman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Talha Abdul Halim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hsueh-Wei Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

17 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

Archivum Immunologiae et Therapiae Experimentalis

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

459-474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25030086%20AND%20SRC:MED&resulttype=core&format=json

Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Odds ratio-based genetic algorithms for generating SNP barcodes of genotypes to predict disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The importance of integrating SNP and cheminformatics resources to pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Preventive SNP-SNP interactions in the mitochondrial displacement loop (D-loop) from chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Genetic algorithm-generated SNP barcodes of the mitochondrial D-loop for chronic dialysis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

(E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

An improved PSO algorithm for generating protective SNP barcodes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Improved branch and bound algorithm for detecting SNP-SNP interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

SNPs in cancer research and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The pharmacogenetics research network: from SNP discovery to clinical drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

αB-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Three polymorphisms in the 3' UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Survival factor NFIL3 restricts FOXO-induced gene expression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Guanylate cyclase activator YC-1 enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells via activation of apoptosis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Retracted: Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: The Activation of the ASK1-ERK-Sp1 Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

PDGF BB induces VEGF secretion in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

A type III effector antagonizes death receptor signalling during bacterial gut infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

PDGF induced microRNA alterations in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Aspidin BB, a phloroglucinol derivative, induces cell cycle arrest and apoptosis in human ovarian HO-8910 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Particle swarm optimization algorithm for analyzing SNP-SNP interaction of renin-angiotensin system genes against hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Evaluation of breast cancer susceptibility using improved genetic algorithms to generate genotype SNP barcodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-014-0307-9